Non-Profit Institution

National Health Research Institutes

Pipelines & Platforms

Focus on innovative therapeutics across cancer, autoimmune, metabolic, and pain indications
Development of advanced vaccine manufacturing platforms
Key highlights include:
Orally bioavailable, site-selective covalent STING inhibitor for autoimmune diseases
Gut FcRn–IgG checkpoint targeting
metabolic inertia